Hufner M, Grussendorf M, Lorenz U, et al. 3,3′,5′‐Triiodothyronine (reverse T3) in amniotic fluid and cord serum. Eur J Pediatr 1977; 125:213.345 345. Stefanovic V, Loukovaara M. Amniotic fluid cardiac troponin T in pathological pregnancies with evidence of chronic fetal hypoxia. Croat Med J 2005; 46: 801.
346 346. Menon R, Thorsen P, Vogel I, et al. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)‐alpha and soluble TNF receptors in spontaneous preterm birth. Am J Obstet Gynecol 2008; 198: 533 e1.
347 347. Park CW, Park JS, Shim SS, et al. An elevated maternal plasma, but not amniotic fluid, soluble fms‐like tyrosine kinase‐1 (sFlt‐1) at the time of mid‐trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol 2005; 193:984.
348 348. Enlander D. Amniotic fluid indicators of fetal maturity. Obstet Gynecol 1972; 40:605.
349 349. Kobayashi H, Suzuki K, Sugino D, et al. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol 1999; 180:141.
350 350. Wallingford JC, Milunsky A, Underwood BA. Vitamin A and retinol‐binding protein in amniotic fluid. Am J Clin Nutr 1983; 38:377.
351 351. Gardiki‐Kouidou P, Seller MJ. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin Genet 1988; 33:441.
352 352. Weisman Y, Jaccard N, Legum C, et al. Prenatal diagnosis of vitamin D‐dependent rickets, type II: response to 1,25‐dihydroxyvitamin D in amniotic fluid cells and fetal tissues. J Clin Endocrinol Metab 1990; 71:937.
353 353. Lacourt GC, Arendt J, Cox J, et al. Microcephalic dwarfism with associated low amniotic fluid 5‐hydroxyindole‐3‐acetic acid (5HIAA). Report of a case of Cornelia de Lange syndrome. Helv Paediatr Acta 1977; 32:149.
354 354. Weiss PA, Kainer F, Haeusler M, et al. Amniotic fluid insulin levels in nondiabetic pregnant women: an update. Arch Gynecol Obstet 1998; 262:81.
355 355. Johnson MR, Abbas A, Nicolaides KH, et al. Distribution of relaxin between human maternal and fetal circulations and amniotic fluid. J Endocrinol 1992; 134:313.
356 356. Caserta D, Mantovani A, Ciardo F, et al. Heavy metals in human amniotic fluid: a pilot study. Prenat Diagn 2011; 31:792.
357 357. Caserta D, Graziano A, Lo Monte G, et al. Heavy metals and placental fetal‐maternal barrier: a mini‐review on the major concerns. Eur Rev Med Pharmacol Sci 2013; 17:2198.
358 358. Chez RA, Henkin RI, Fox R. Amniotic fluid copper and zinc concentrations in human pregnancy. Obstet Gynecol 1978; 52:125.
359 359. Nusbaum MJ, Zettner A. The content of calcium, magnesium, copper, iron, sodium, and potassium in amniotic fluid from eleven to nineteen weeks' gestation. Am J Obstet Gynecol 1973; 115:219.
360 360. Keppen LD, Pysher T, Rennert OM. Zinc deficiency acts as a co‐teratogen with alcohol in fetal alcohol syndrome. Pediatr Res 1985; 19:944.
361 361. Ward N, Bryce‐Smith DM, Minski M, et al. Multi element neutron activation analysis of amniotic fluid in relation to varying gestational membrane ruptures. In: Bratter P, Schramel P, eds. Analytical chemistry in medicine and biology. Proceedings of the 2nd International Workshops. Berlin: de Gruyter, 1983:483.
362 362. Parkinson CE, Tan JC, Gal I. Vitamin A concentration in amniotic fluid and maternal serum related to neural tube defects. Br J Obstet Gynaecol 1982; 89:935.
363 363. Parkinson CE, Tan JC, Lewis PJ, et al. Amniotic fluid zinc and copper and neural tube defects. J Obstet Gynaecol 1981; 1:207.
364 364. Tamura T, Weekes EW, Birch R, et al. Relationship between amniotic fluid and maternal blood nutrient levels. J Perinat Med 1994; 22:227.
365 365. Dawson EB, Evans DR, Van Hook JW. Amniotic fluid B12 and folate levels associated with neural tube defects. Am J Perinatol 1998; 15:511.
366 366. Dawson EB, Evans DR, Harris WA, et al. Amniotic fluid B12, calcium, and lead levels associated with neural tube defects. Am J Perinatol 1999; 16: 373.
367 367. Luglie PF, Frulio A, Campus G, et al. Dosaggio del mercurio nel liquido amniotico umano [Mercury determination in human amniotic fluid]. Minerva Stomatol 2000; 49:155.
368 368. Kozikowska I, Binkowski LJ, Szczepanska K, et al. Mercury concentrations in human placenta, umbilical cord, cord blood and amniotic fluid and their relations with body parameters of newborns. Environ Pollut 2013; 182:256.
369 369. Milnerowicz H, Zalewski J, Geneja R, et al. Poziom metali Cd i Pb we krwi oraz Zn, Cu, Cd i Pb w wodach płodowych kobiet palacych papierosy podczas ciazy powikłanej małowodziem lub przedwczesnym odpływaniem w'od płodowych [Levels of Cd, Pb in blood and Zn, Cu, Cd, Pb in amniotic fluid of tobacco smoking women during pregnancy complicated oligohydramnios or premature rupture of membranes]. Ginekol Pol 2000; 71:311.
370 370. Hodari AA, Mariona FG, Houlihan RT, et al. Creatinine transport in the maternal–fetal complex. Obstet Gynecol 1973; 41:47.
371 371. Droegemueller W, Jackson C, Makowski EL, et al. Amniotic fluid examination as an aid in the assessment of gestational age. Am J Obstet Gynecol 1969; 104: 424.
372 372. Sharma SD, Trussell RR. The value of amniotic fluid examination in the assessment of fetal maturity. J Obstet Gynaecol Br Commonw 1970; 77:215.
373 373. Muller F, Bernard MA, Benkirane A, et al. Fetal urine cystatin C as a predictor of postnatal renal function in bilateral uropathies. Clin Chem 1999; 45:2292.
374 374. Renwick JH, Lawler SD. Genetical linkage between the ABO and nail‐patella loci. Ann Hum Genet 1955; 19:312.
375 375. Bongers EM, de Wijs IJ, Marcelis C, et al. Identification of entire LMX1B gene deletions in nail patella syndrome: evidence for haploinsufficiency as the main pathogenic mechanism underlying dominant inheritance in man. Eur J Hum Genet 2008; 16:1240.
376 376. Renwick JH, Bundey SE, Ferguson‐Smith MA, Izatt MM. Confirmation of linkage of the loci for myotonic dystrophy and ABH secretion. J Med Genet 1971; 8:407.
377 377. Milunsky A, Skare JC, Milunsky JM, et al. Prenatal diagnosis of myotonic muscular dystrophy with linked deoxyribonucleic acid probes. Am J Obstet Gynecol 1991; 164:751.
378 378. Kamsteeg EJ, Kress W, Catalli C, et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 2012; 20:1203.
379 379. Durandy A, Cerf‐Bensussan N, Dumez Y, et al. Prenatal diagnosis of severe combined immunodeficiency with defective synthesis of HLA molecules. Prenat Diagn 1987; 7:27.
380 380. Dundar O, Yoruk P, Tutuncu L, et al. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction. Prenat Diagn 2008; 28:887.
381 381. Davis LE, McLaren LC, Stewart JA, et al. Immunological and microbiological studies of midtrimester amniotic fluid. Gynecol Obstet Invest 1983; 16:261.
382 382. Boulley AM, Vial M, Bessis R, et al. Diagnostic antenatal de deux cas de maladie des inclusions cytomegaliques [Antenatal diagnosis of 2 cases of cytomegalic inclusion disease]. Arch Fr Pediatr 1984; 41:123.
383 383. Auger P, Marquis G, Dallaire L, et al. Natural occurrence of a humoral response
